A Study of Preferences for the First-Line Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer
Clinical trial NCT05250817 · COMPLETED
Trial details
- NCT number
- NCT05250817
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-12-09
- Primary completion
- 2023-01-04
- Enrollment
- 501
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.